To study the efficacy of Dhanyaka-gokshuradi ghrita in comparison with Tamsulosin hydrochloride for the treatment of benign enlargement of prostate

randomized controlled clinical study to evaluate the efficacy of dhanyaka-gokshuradi ghrita in comparison with tamsulosin hydrochloride in the management of benign enlargement of prostate - management of BEP

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029728

Enrollment

Registered

2020-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Dhanyaka-gokshuradi ghrita: Patient will be selected and treated with Dhanyaka-gokshuradi ghrita drug doses 10 ml once a day (apaan kaal) Duration of Drug 21 days Control Intervention1:

Eligibility

Inclusion criteria

Inclusion criteria: •A known diagnosed case of (benign enlargement of prostate) on the basis of clinical and investigative methods. •Male patient of age group more than 40 -60 yrs. Irrespective of religion and occupation. •Prostate size below 35 gms

Exclusion criteria

Exclusion criteria: • Acute/chronic retention of urine, stone formation, renal failure. •Bladder neck stenosis, bladder diverticulum, neurogenic bladder, neoplasm of bladder, urethral stricture. •CA prostate, Prostitis.

Design outcomes

Primary

Measure	Time frame
1)Benign enlargement of prostate is one of the most common diseases in ageing men and most common cause of lower urinary tract symptoms_ The prevalence of BEP increases after the age of 40 years. Genetics, diet and life style also Contributes for BEP. 2)To evaluate the and establish safer,cost-effective Dhanyaka-gokshuradi ghrita in the management of benign enlargement of prostate-[management of benign enlargement of prostate]Timepoint: Duration of treatment 21days total	—

Measure

Time frame

1)Benign enlargement of prostate is one of the most common diseases in ageing men and most common cause of lower urinary tract symptoms_ The prevalence of BEP increases after the age of 40 years. Genetics, diet and life style also Contributes for BEP. 2)To evaluate the and establish safer,cost-effective Dhanyaka-gokshuradi ghrita in the management of benign enlargement of prostate-[management of benign enlargement of prostate]Timepoint: Duration of treatment 21days total

—

Secondary

Measure	Time frame
Dhanyaka-gokshuradi ghrita is effective the management of benign enlargement of prostate-[management of benign enlargement of prostate]Timepoint: 21 days study with 4 follow up (0,7,14,21 days)	—

Countries

India

Contacts

Public ContactDr Sayali Babasaheb Gore

Dr D Y Patil College Of Ayurveda And Research Centre Pimpri Pune

sanjaybabar14@gmail.com9011035602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026